Progesterone inhibition of oxytocin signaling in endometrium by Cecily V. Bishop
MINI REVIEW ARTICLE
published: 07 August 2013
doi: 10.3389/fnins.2013.00138
Progesterone inhibition of oxytocin signaling in
endometrium
Cecily V. Bishop*
Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA
Edited by:
John J. Peluso, University of
Connecticut Health Center, USA
Reviewed by:
James K. Pru, Washington State
University, USA
Keith Inskeep, West Wirginia
University, USA
*Correspondence:
Cecily V. Bishop, Division of
Reproductive and Developmental
Sciences, Oregon National Primate
Research Center, Oregon Health &
Science University, 505 NW 185th
Ave., Beaverton, OR 97006, USA
e-mail: bishopc@ohsu.edu
Expression of the oxytocin receptor (OXTR) in the endometrium of ruminant species is
regulated by the ovarian steroids progesterone (P) and estradiol (E). Near the end of
the estrous cycle, long-term exposure of endometrial epithelial cells to P results in loss
of genomic P receptors (PGRs), leading to an increase in E receptors (ERs). Genomic
regulation of the OXTR is mediated via suppression of ER signaling by P. Upon OT binding
at the plasmamembrane of endometrial cells, a signaling cascade is generated stimulating
release of prostaglandin F2α (PGF2α). Transport of PGF2α to the ovary results in release of
OT by luteal cells in a positive feedback loop leading to luteal regression. This signaling
cascade can be rapidly blocked by exposing endometrial cells to physiologic levels of
P. This mini review will focus on the mechanisms by which P may act to block OXTR
signaling and the luteolytic cascade in the ruminant endometrium, with special focus on
both non-genomic signaling pathways and non-receptor actions of P at the level of the
plasma membrane. While this review focuses on ruminant species, non-classical blockage
of OXTR signaling may be important for fertility in women.
Keywords: oxytocin, oxytocin receptor, progesterone, non-genomic steroid hormone action, non-classical steroid
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INTRODUCTION
In mammals, signaling by the neuropeptide oxytocin (OT) via
receptors (OXTRs) in the uterus results in initiation of parturi-
tion [as reviewed by Kamel (2010)] and contributes to initiation
of luteolytic events in some species (Lee et al., 2010). The effects of
OT signaling via uterine OXTRs are especially well-characterized
in ruminant species. The luteal steroid progesterone (P) can block
OXTR signaling via several mechanisms, however, the exact medi-
ator(s) of this response remain to be conclusively identified in
uterine tissues.
OXYTOCIN AND OXYTOCIN RECEPTOR (OXTR)
OT is a neuropeptide with the amino acid sequence of Cys-
Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2; OT is secreted primarily
from the posterior pituitary, but also by the corpus luteum (CL)
of several mammalian species such as swine, ruminants, and pri-
mates [as reviewed by Stormshak (2003)]. The OXTR is expressed
in OT-target tissues (such as the uterus) and is a class 1 G-
protein coupled receptor (GPCR) which primarily activates the
G-protein αq/11 upon OT binding [as reviewed by Sanborn
et al. (1995)]. Activation of the receptor by Gαq stimulates the
enzyme phospholipase (PLC)β, which hydrolyzes phosphatidyli-
nositol 4,5-bisphosphate, generating 1,2 diacylglycerol (DAG)
and inositol 1,4,5-trisphosphate (IP3). Production of IP3 by the
OT -stimulated uterine cell causes the endoplasmic reticulum
to release stored calcium (Ca2+; Figure 1). Intracellular Ca2+
release activates protein kinase C (PKC), which phosphorylates
many regulatory proteins (Blanks et al., 2007), while free arachi-
donic acid is cleaved from DAG and converted into prostaglandin
F2α (PGF2α) in endometrial cells [as reviewed by Gimpl and
Fahrenholz (2001)].
OXYTOCIN-MEDIATED LUTEOLYSIS IN RUMINANT SPECIES
Functional OXTRs are expressed in the endometrium of the
uterus in ruminant species such as the ewe near the end of
diestrus (Stevenson et al., 1994). At this time, OT secreted
by large luteal cells of the CL (Fields and Fields, 1986) acti-
vates OXTR signaling in the endometrium resulting in secre-
tion of PGF2α [as reviewed by Niswender et al. (2007)].
Endometrial PGF2α is transported directly via ovarian artery
to the CL where it induces further release of OT (Lee et al.,
2010), in a positive feedback loop that ultimately results
in luteal regression. The ruminant conceptus secretes inter-
feron tau (IFNT), which acts to block/prevent OXTR signal-
ing and prolong luteal life span [as reviewed by Spencer et al.
(2007)].
The involvement of OT and OXTR in luteal regression of
primates is still controversial. Unlike ruminant CL, transplan-
tation of the ovary away from the uterine blood supply does
not prolong luteal lifespan in primates, indicating an intra-
luteal mechanism of luteolysis (Burford and Diddle, 1936; Beavis
et al., 1969). Several studies in non-human primates suggest
that OT increases P secretion from early luteal phase CL,
and might be involved with maintenance of gap-junctions in
luteal tissue (Khan-Dawood et al., 1998). More recently, expres-
sion of functional OXTR was reported in human luteinized
granulosa cells (Saller et al., 2010). Activation of the OXTR
by OT increases caspase signaling and induces morphological
changes to luteinized granulosa cells associated with regres-
sion. Therefore, while there is evidence that the OXTR is
involved in primate luteal regression, additional well-designed
studies are needed to precisely define its role in primate
luteolysis.
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FIGURE 1 | Progesterone (P) inhibition of oxytocin receptor (OXTR)
signaling in endometrial cells. Binding of oxytocin (OT) to the OXTR
activates the G-protein, Gαq/11. The activated G-protein phosphorylates the
enzyme phospholipase Cβ (PLCβ), which cleaves phosphatidylinositol
4,5-bisphosphate into DAG and inositol 1,4,5-trisphosphate (IP3). Released
IP3 induces intracellular calcium release (Ca2+) from the endoplasmic
reticulum, and is then recycled into free inositol. Free arachadonic acid (AA)
is cleaved from DAG by phospholipase A2 (PLA2) and then converted by
cyclooxygenase 2 (COX2) into prostaglandin F2α (PGF2α). Blockage of this
signaling cascade by P can occur by two mechanisms: (1) P binding to a
membrane-associated binding protein that interacts with the OXTR,
resulting in conformational changes to the receptor such that OT is not able
to bind and/or the OXTR is unable to interact with the G-protein. (2) P
overloading of the plasma membrane results in changes to membrane
fluidity, preventing the OXTR from interacting with the G-protein. Both of
these mechanisms of action would result in P-mediated decreased
signaling of the OXTR.
EFFECTS OF PROGESTERONE ON OXTR GENE EXPRESSION
Following ovulation and luteinization in the ewe, during diestrus
there is an initial increase in expression of the genomic P recep-
tor (PGR) in the uterine endometrial glands, and a concurrent
absence of OXTRs. Blockage of endometrial OXTR expression by
ligand-bound PGR is via an indirect mechanism resulting from P
suppression of estrogen receptors (ERs) [as reviewed by Spencer
and Bazer (2004)]. However, even when OXTR are expressed in
endometrial cells, exposure of the endometrium to both estradiol
(E) and P is absolutely necessary for OT to induce PGF2α secre-
tion (Vallet et al., 1990). This is most likely due to P modulation
and/or up-regulation of the necessary precursors in endome-
trial cells for prostaglandin production [as reviewed by Schams
and Berisha (2002)]. The ruminant OXTR has been cloned;
the promoter region contains several AP-1 and SP1 transcrip-
tion factor recognition sites, as well as PGR half-sites (Fleming
et al., 2006); genomic regulation of OXTR is mediated by ERα
(ESR1) via these SP-1 sites, with no direct regulation by PGR.
Similarly, IFNT also decreases ESR1 expression, thereby prevent-
ing ESR1-induced transcription of the OXTR gene (Fleming et al.,
2006).
Increased expression of OXTR near parturition is noted in all
mammalian species, including primates and ruminants; OXTR
signaling is critical for initiation of myometrial contractions
in ruminants (Wathes and Hamon, 1993). Genomic PGR
is expressed in near-term myometrium, but PGR-coactivators
decline prior to initiation of labor in women and mice (Condon
et al., 2003). Administration of mifepristone (PGR antagonist)
to women for blockage of PGR signaling can initiate labor
[Cochrane review Hapangama and Neilson (2009)]. This sug-
gests direct suppression of the OXTR near term by P via
PGR signaling. But, regulation of OXTR gene function by P
in pregnant myometrium is most likely indirect via immuno-
suppressive actions of P [as reviewed by Arck et al. (2007)].
Recently, binding sites for nuclear factor-kappa B p65 (RELA)
and CCAAT/enhancer-binding protein (CEBP) were identified
in the human OXTR gene promotor region (Khanjani et al.,
2011). Expression of CEBP and RELA are increased in inflam-
matory responses (Adams et al., 2000), and mediators of both are
increased in near-term myometrium of women (Khanjani et al.,
2011).
Most notably, microarray analyses of P-response genes in
murine endometrium at early pregnancy did not find that the
Oxtr gene was altered by progestin replacement following ovariec-
tomy (Jeong et al., 2005). Moreover, while mRNA for OXTR is
expressed in rhesus luteal tissue during the mid-late luteal phase
(identified bymicroarray analysis), it is not regulated by progestin
[GEO dataset Series GSE12281 (Bishop et al., 2009)]. Given these
data along with the previously noted studies in ruminants and
women, it is likely that P regulation of the OXTR gene is indi-
rect via modulation of other factors, such as ESR1 and immune
factors.
NON-GENOMIC INHIBITION OF OXTR SIGNALING BY P;
EVIDENCE OF BIOLOGICAL SIGNIFICANCE
Evidence for non-genomic inhibition of uterine OXTR signal-
ing includes the observation that P and metabolites of P rapidly
inhibit contractions of rat uteri within 2min of treatment; this
response is not opposed by treatment with the PGR antagonist
RU 486 (Putnam et al., 1991). While these authors suggest that
GABAA receptors mediate these effects, the rodent uterus also
secretes OT, suggesting that the effects of P might be via non-
genomic inhibition of rodent Oxtr signaling. Indeed, later studies
from Grazzini et al. (1998) demonstrated that P induces a reduc-
tion in rat uterine OT signaling without a change in Oxtr mRNA
expression.
Later studies in non-pregnant ruminants (Bogacki et al.,
2002) demonstrated that P could inhibit OT-induced intracel-
lular calcium release and PGF2α secretion by bovine endome-
trial tissue explants in the presence of actinomycin D, an
inhibitor of DNA transcription/mRNA synthesis. However,
subsequent experiments revealed P as well as pregnenolone,
17β-hydroxyprogesterone, the PR antagonist onapristone, and
testosterone at micromolar (μM) concentrations were all able
to interfere with OT-stimulated PGF2α secretion and intracel-
lular calcium release (Duras et al., 2005). Inhibition of both
OT-induced IP3 accumulation and PGF2α release from ovine
endometrial explants was later observed at lower nM concen-
trations of P within hours (Bishop and Stormshak, 2006). This
rapid, specific inhibition of OXTR signaling by P was confirmed
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in COS7 (African green monkey kidney) cells transfected with the
ovine OXTR that lack PGRs (Bishop et al., 2008).
Incubation of myometrial strips from women at term preg-
nancy with P decreased OT-induced contractility within 20min
to an hour in a concentration–dependent manner, with maxi-
mal inhibition at 10μMP (Chanrachakul et al., 2005). This could
indicate a role for non-genomic inhibition of OXTR signaling by
P to prevent premature onset of parturition.
MOLECULAR ACTIONS OF NON-GENOMIC INHIBITION OF OXTR
SIGNALING BY P
Rapid inhibition of rodent Oxtr signaling is due to a P-mediated
decrease in OT binding capacity, not binding affinity (Grazzini
et al., 1998). Inhibition of OT binding is P dose-dependent and
specific to the Oxtr (i.e., no effect on a related GPCR, vaso-
pressin receptor). The observed inhibition by P of Oxtr function
is at the level of the plasma membrane: P conjugated to bovine
serum albumin, which prevents P from crossing through the
plasma membrane easily, also inhibited membrane binding of
OT. Specific and high-affinity binding sites for P were reported
only in transfected CHO cells expressing the Oxtr. Moreover,
high-affinity binding of P to Oxtr-expressing membranes was
regulated by the state of the G-protein coupling to the receptor,
based on additional experiments performed with the G-protein
uncoupling reagent GTPγS. These observations indicate that the
interaction of P with the rodent Oxtr is possibly a direct steroid-
receptor interaction, either by altering the conformation of the
receptor or directly blocking the binding site for OT on the OXTR
(Grazzini et al., 1998).
Later investigations of the ovine OXTR validated these initial
studies in rodents. Isolated membrane fractions from the uter-
ine luminal epithelium of artificially-cycled, ovariectomized ewes
pre-incubated with P showed decreased OT binding, which was
reversed by co-incubation with RU 486 (Dunlap and Stormshak,
2004). The presence of high-affinity membrane binding sites for P
were identified, with P saturation occurring at 8 nM (Kd = 1.2 ×
10−9 M). E, cortisol, testosterone, and arginine vasopressin failed
to compete for the P binding site, however, P, R5020 (synthetic
progestin), RU 486, and OT all bound to the same site on plasma
membranes. A radioreceptor exchange assay demonstrated that
pre-exposure of membranes to P significantly increased the num-
ber of P binding sites. Inhibition of OT binding to endometrial
membranes by P was dose-dependent at a low (nM) steroid con-
centration (Bishop and Stormshak, 2006). However, unlike the
rodentOxtr (Grazzini et al., 1998) and native OXTR expression in
ovine endometrial membranes (Dunlap and Stormshak, 2004), P
does not decrease specific OT binding to the ovine OXTR when
transfected into the COS7 (African green monkey kidney fibrob-
last) cell line (Bishop et al., 2008). Additionally, no specific P
binding sites were identified in membranes of OXTR-transfected
COS7 cells. This cell line (COS7) was chosen for transfection due
to the fact that it lacked P receptors. While CHO (Chinese ham-
ster ovary) cells are not reported to contain PGRs, the observed
discrepancy between the two experiments (Grazzini et al., 1998;
Bishop et al., 2008) could be due to the fact that CHO cells are
of reproductive tract origin (unlike COS7) and may express a P
binding protein.
Effects of progestins to inhibit a primate OXTR transfected
into various cell lines was only investigated using μM con-
centration of steroid (Burger et al., 1999). This study reported
that P inhibited the signaling of several related GPCRs (includ-
ing acetylcholine receptor and vasopressin receptor) as well as
the OXTR, suggesting that these effects are non-specific at μM
concentrations of P.
POSSIBLE NON-GENOMIC MEDIATORS OF P-INHIBITION OF OXTR
SIGNALING
As noted in several studies (Burger et al., 1999; Duras et al.,
2005), μM concentrations of many classes of steroids have non-
specific effects on OXTR signaling apparently in absence of
specific binding of steroid to a single receptor. Non-receptor-
mediated effects of various steroids, including P, were reported
from studies of lipid domains using artificial membrane bilay-
ers (Wenz and Barrantes, 2003). The lower the hydrophobicity
of the steroid, (determined by the group bound to C17) the
more disruptive the steroid is to lipid domains at μM molar
concentrations. The composition and presence of these lipid
domains in cell membranes may be critical to GPCR signal-
ing (Bruno et al., 2012). P, promegestone, pregnenolone, 11
α-hydroxyprogesterone, and 17 α- hydroxypregnenolone all pos-
sess low hydrophobicity groups attached to C17 and demonstrate
domain-disrupting activity at μM concentrations (Wenz and
Barrantes, 2003). The previously mentioned study of Burger et al.
(1999), found that the mechanism by which P inhibited signaling
of several related GPCRs was possibly due to an observed decrease
in plasma membrane fluidity. Therefore, the non-specific effect
of several steroids on OXTR signaling at higher μM concentra-
tions may be due to disruption of the lipid bilayer by steroid
overloading of the plasma membrane. Steroid overloading of the
membranes may affect OXTR coupling to the G-protein and acti-
vation of downstream signaling effectors by changing the fluidity
of the plasma membrane (Gimpl et al., 2002), and preventing
conformational changes of the receptor from inducing down-
stream effectors. This is a likely mechanism when local levels of
steroids are high, such as during gestation (from placental P)
and in the luteal tissue itself. In bovine CL, OXTRs are localized
to pure preparations of small, steroidogenic luteal cells (SLCs),
which release Ca2+ in response to OT-stimulus (Davis et al.,
2010). If these SLCs are pre-incubated for 1 h with a high con-
centration of P (∼100μM), the OT-stimulated intracellular Ca2+
release is blocked. Because this phenomena was mimicked by
replacing P with a cyclodextrin (methyl-β cyclodextrin), P might
be acting to exclude cholesterol from the plasma membrane, thus
altering membrane fluidity in these SLCs (Davis et al., 2010).
However, data generated from experiments in ovine endome-
trial tissue (Dunlap and Stormshak, 2004; Bishop and Stormshak,
2006), demonstrating a specific and saturable binding site for
P that is closely associated with the OXTR suggests that rapid
inhibition of OXTR signaling by P in reproductive tissues may
be receptor mediated. A non-PGR, P receptor membrane com-
ponent 1 (PGRMC1) and associated serpine mRNA binding
protein 1 (SERBP1) are expressed in the uterus (endometrium
and myometrium) of ruminants (Luciano et al., 2011) and non-
human primates (Keator et al., 2012), and in human ovarian
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tissue (Luciano et al., 2011). Expression and actions of these pro-
teins are extensively characterized in granulosa cells (Peluso et al.,
2006), where the main function is preventing apoptosis. Given
the fact that OXTR is expressed in primate luteal tissue and OT
might contribute to intra-luteal initiation/progression of primate
luteolysis (Saller et al., 2010); a membrane PR may prevent local
OXTR signaling in the CL. Our research group observed expres-
sion of PGRMC1 protein present in the granulosa lutein cells of
the rhesus macaque CL throughout the entire luteal phase, with
intense staining noted in distinct subpopulations of cells clus-
tered around the periphery of the CL (Bishop, Bogan, Slayden,
Hennebold, and Stouffer, Unpublished). Expression of PGRMC1
mRNA in luteal tissue peaks at the late luteal phase, just prior
the fall in P levels, and PGRMC1 protein is increased follow-
ing chorionic gonadotropin exposure simulating early pregnancy
(Bishop et al., 2011). In the ruminant uterus, evaluation of
PGRMC1 expression by immunohistochemistry showed robust
staining of bovine luminal epithelium (Luciano et al., 2011), the
same cell type express OXTR (Leung et al., 2001). Possible effects
and/or interactions between PGRMC1 and OXTR in the plasma
membrane of both the endometrium and the CL remain to be
investigated.
Other novel, non-genomic membrane PRs (mPRs) have been
identified in the ovine uterus which may act to block local OXTR
signaling (Ashley et al., 2009). While the function(s) of the mPR
have yet to be described in the ewe, it reportedly stimulates
intracellular calcium release. Three homologues of the mPR are
present in the human uterus: mPRα, β, and γ (Fernandes et al.,
2005). Endometrial mRNA expression of mPRα and mPRβ dif-
fer by the stage of the menstrual cycle; both decrease at the onset
of parturition (Fernandes et al., 2005). These mPR are GPCRs,
functioning to inhibit adenylcyclase activity (coupled to Gαi).
The effect these mPRs might exert on OXTR signaling in uterine
tissues remains to be investigated.
The genomic PGR also rapidly activates the MAPK pathway
upon stimulation in breast cancer cells via a SRC kinase-like SH3
Table 1 | Studies of progesterone inhibition of OXTR signaling.
Species Citation Major findings
Rodent Putnam et al., 1991 P and P metabolites rapidly inhibit contractions of rat uteri within 2min of treatment
Effect of P not opposed by treatment with the PGR antagonist RU 486
Grazzini et al., 1998 P reduced rat uterine OT signaling without a change in Oxtr mRNA expression
Inhibition due to a P-mediated decrease in OT binding capacity, not binding affinity
Occurred at the level of the plasma membrane
Specific and high affinity binding sites for P only in transfected CHO cells expressing Oxtr with high
affinity
Regulated by the state of the G-protein coupling to the receptor
Ovine Dunlap and Stormshak, 2004 Isolated membrane fractions pre-incubated with P showed decreased OT binding, reversed by
co-incubation with RU 486
High affinity binding site for P
P, R5020 (synthetic progestin), RU 486, and OT all bind to the same site pre-exposure of membranes
to P significantly increased the number of P binding sites
Bishop and Stormshak, 2006 P binding to endometrial membranes is dose dependent
Inhibition of both OT-induced IP3 accumulation and PGF2α release from ovine endometrial explants by
P within hours of exposure
Bishop et al., 2008 Rapid, specific inhibition of OXTR signaling by P in COS7 cells transfected with the ovine OXTR that
lack PGRs
P did not decrease specific binding of OT
No specific P binding sites in membranes of OXTR-transfected cells
Bovine Bogacki et al., 2002 P inhibited OT binding at all concentrations (20–0.002μM) investigated
OT-induced intracellular calcium release and PGF2α secretion by bovine endometrial tissue explants in
the presence of actinomycin D
Duras et al., 2005 P as well as pregnenolone, 17β-hydroxyprogesterone, the PR antagonist onapristone, and
testosterone at μM concentrations were all able to interfere with OT-stimulated PGF2α secretion and
intracellular calcium release
Davis et al., 2010 P at μM concentration rapidly (within 1 h) inhibited OT-induced Ca2+ release from endoplasmic
reticulum of small steroidogenic luteal cells, possibly via exclusion of cholesterol from the luteal cell
plasma membrane
Primate/Human Burger et al., 1999 μM concentration of P inhibited the signaling of several related GPCRs as well as the OXTR
Chanrachakul et al., 2005 Within 20min-1h P decreased OT-induced contractility of term myometrium in a concentration
dependent manner
Maximal inhibition at 10μM P
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domain (Faivre et al., 2005; Skildum et al., 2005). The OXTR can
also activate the MAPK pathway (Devost et al., 2008), but given
the evidence that interference of OT binding to the OXTR occurs
at the level of the plasmamembrane (Grazzini et al., 1998; Dunlap
and Stormshak, 2004; Bishop and Stormshak, 2006), involvement
of the cytoplasmic/nuclear PGR to directly block OXTR signaling
is unlikely. There is limited data on membrane-associated PGR,
however, a microarray-based analysis did identify a membrane-
associated mRNA encoding the PGR, suggesting localization to
the plasma membrane (Diehn et al., 2006). Further studies are
needed to clarify any non-genomic effects of PGR to block OXTR
signaling.
CONCLUSIONS
There is evidence that P directly antagonizes OXTR signal-
ing via a non-genomic mechanism, however, there are only
a few studies, some with conflicting results (summarized in
Table 1). Experiments conducted on the ruminantOXTR demon-
strate rapid blockage of OT-stimulated secretion of PGF2α from
endometrial tissue by P, which could lead to delayed luteolytic
events. The best-characterized tissue to date of regulation of
OXTR expression and OT signaling is the ruminant uterus, how-
ever, rapid inhibition of OT action by P remains to be investigated
in the ruminant uterus during pregnancy. Inhibition of OXTR
signaling may be due to non-receptor mediated events related to
steroid overloading of plasma membranes, or via specific bind-
ing of P to one of several membrane-associated P receptors
(Figure 1). Nevertheless, while there is ample evidence support-
ing an OXTR-associated P binding site in situ, further studies
are needed to elucidate any involvement of membrane P recep-
tors in blockage of OXTR signaling. The role of an ovarian
OXTR in regulation of primate luteal tissue remains unclear, but
P may act to block local OXTR signaling. Given recent stud-
ies identifying functional OXTR in primate luteal cells and P
inhibition of OT-signaling in bovine SLCs (Davis et al., 2010),
further experiments could help identify causes of fertility dis-
orders associated with luteal function in women. Additionally,
molecular mechanisms regulating parturition and onset of labor
in women are still being defined. Greater understanding of
OXTR signaling in the primate uterus might help reduce com-
plications from onset of preterm labor (Hubinont and Debieve,
2011).
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